Johan Askling

Professor

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Johan Askling is a Professor at Karolinska Institutet in Sweden. His research focuses on the epidemiology of inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease. He has authored several recent articles examining the impact of these conditions on comorbidities, treatment outcomes, and associated health risks. His work contributes to understanding the intersection of autoimmune diseases and their societal implications.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (24)

Marie Linder

Karolinska Institutet

SWEDEN

Johan Askling

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors

Adult-onset inflammatory bowel disease and the risk of venous thromboembolism – a Swedish nationwide cohort study 2007–2021

Exposure to antibiotics and risk of latent autoimmune diabetes in adults and type 2 diabetes: results from a Swedish case–control study (ESTRID) and the Norwegian HUNT study

Impact of incident rheumatoid arthritis on earnings: a nationwide sibling comparison study

In early rheumatoid arthritis, comorbidities do not explain the increased risk of failure to reach remission in patients with obesity

Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study

Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies

Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population‐ and Sibling‐Controlled Cohort and Cross‐Sectional Analyses

Microscopic colitis and risk of incident rheumatoid arthritis: A nationwide population‐based matched cohort study

Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods

Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts

Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register

Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study

The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study

Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis

Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study

Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis

Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis

Collaborators (24)

Marie Linder

Eli Westerlund

Carl Turesson

Jonas Halfvarson

Anders Forss

Merete Lund Hetland

Espen André Haavardsholm

Carl Eriksson

Eva Klingberg

LTH Jacobsson

Helena Forsblad-d'Elia

Tiinamaija Tuomi

Lars Klareskog

AnnaCarin Horne

Daniela Di Giuseppe

Jonas Ludvigsson

Elisabet Lindqvist

Martin Neovius

Benedicte Delcoigne

Jiangwei Sun

Thomas Frisell

Ulf Lindström

Gabriella Bröms

Johan Reutfors

Make your next move.